Elevance Health, Inc.
439.95USD
-5.3300 (-1.20%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on ELV.
| In $M except per-share | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 51,429 | 50,474 | 50,181 | 49,747 | 50,711 | 49,776 | 48,891 | 45,442 |
| Cost of Revenue | 5,640 | 5,492 | 5,463 | 5,522 | 5,380 | 5,293 | 4,983 | 6,012 |
| Gross Profit | 45,789 | 44,982 | 44,718 | 44,225 | 45,331 | 44,483 | 43,908 | 39,430 |
| Operating Income | 1,269 | 1,763 | 2,086 | 309 | 1,295 | 2,425 | 3,170 | 673 |
| Net Income | 1,365 | 1,463 | 1,764 | 547 | 1,189 | 1,743 | 2,183 | 418 |
| EPS (Diluted) | $6.27 | $6.71 | $8.00 | $2.54 | $5.32 | $7.72 | $9.61 | $1.87 |
Source: SEC filings (EDGAR)